Blue Horseshoe Stocks: RSH Update & More

Radio Shack Corp. RSH

RSH has made regular appearances in our reports over the past couple of months, starting in the beginning of August, when we caught the stock off of its 52-week low of .55.

Following a major run-up to the 1.60-range on August 29th, the stock has been under a general consolidation amid bankruptcy rumors. This week, the company was hinting at possible refinancing deal that would allow them to avoid that situation for the time being, and this morning, that deal was confirmed.

As a result, the stock is up significantly today, having traded as high 1.65 in the premarket. We’re going to want to see support hold at previous resistance points at 1.15 and 1.30. Already, at today’s early highs, we’re seeing more than a 100% increase off of the lows we observed following our most recent RSH alert (.80)


Rockwell Medical, Inc. RMTI

RMTI is another morning gapper that we’re going to place on watch today. With the stock coming off of a recent bottom, it’s going to be interesting to see how today’s development affects its price action.

The company put out a hefty PR this morning regarding a commercialization/distribution deal with Baxter Healthcare (BAX):

WIXOM, Mich., Oct. 3, 2014 (GLOBE NEWSWIRE) — Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with innovative products and services for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis, announced today that it has signed an exclusive agreement with Baxter Healthcare Corporation, a subsidiary of Baxter International Inc. (BAX), to commercialize Rockwell’s hemodialysis concentrate product line in the U.S. and in select overseas markets.>> VIEW PR


BioCryst Pharmaceuticals, Inc. BCRX

BCRX appeared on Wednesday in our extended watchlist, and what has followed has been two fruitful sessions in a row. From a low of 9.89 on Wednesday, we witnessed as the stock bulled its way into yesterday’s close, reaching a daily high of 11.49, a solid 16% overnight increase.


Inovio Pharmaceuticals, Inc. INO

Speaking of pharma plays, INO, a stock that has appeared several times in our reports recently, is also making moves concurrently with the present concern over the Ebola virus outbreak. The company actually has a Ebola vaccine with which they’ve reported success in treating animals with the deadly virus. Anything to do with Ebola is getting a lot of attention at present, and INO is no exception.


Side Note:

Jobs numbers were out this morning, to a positive reception. We will subsequently be looking for dip-and-rip opportunities with regard to options trading. Friday is characteristically a day when premiums start to come down as a result of time decay, with expirations looming. We’re looking at potential opportunities trading Calls in plays like SPY, AA, ISRG, & GPRO.


Extended Watchlist:
HALO, JBLU, WAVX, IAG, SFUN, NXTD